Actinogen Limited

ASX:ACW ISIN:AU000000ACW3

 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 12137

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article▸
###

1,478 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 3) (Last 30 Days: 14) (Since Published: 1478) 

Company Data

More News Results

  • 2024/05/08: Application for quotation of securities - ACW*
  • 2024/05/07: ACW lodges Prospectus for entitlement offer of up to $3.9m*
  • 2024/05/07: Prospectus - Non-renounceable Entitlement Offer*
  • 2024/05/03: Proposed issue of securities - ACW*
  • 2024/05/03: Actinogen announces capital raising of up to $8.9 million*
  • 2024/05/01: Trading Halt*
  • 2024/04/30: ACW March 2024 quarterly activity report & Appendix 4C*
  • 2024/04/22: ACW completes cognition & depression phase 2 trial enrolment*
  • 2024/04/15: First patient treated in ACW XanaMIA ph 2b Alzheimers trial*
  • 2024/04/15: Notification of cessation of securities - ACW*
*refer to company website